Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus

NCT01645332 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Type-2-diabetes Mellitus
New Onset

Interventions

DRUG: Placebo of DLBS3233
DRUG: DLBS3233
OTHER: Lifestyle modification

Sponsor

Dexa Medica Group